← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2019Last known activity
Feb 1, 2019
Acquired by Telix on Nov 26, 2018
Timeline
2010s
- Jun 1, 2015
Advanced Nuclear Medicine Ingredients— Founded
- Nov 26, 2018
Telix— Acquired By
Drugs by trial phase (2 distinct, 1 trials)
Phase 3 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT03623425CollaboratorPhase 3Feb 1, 2019
Details
- Founded
- Liege, BE Jun 1, 2015
- Last known activity
- Feb 1, 2019